Ritedose recalls 23.4% Sodium Chloride Injection with incorrect barcode labeling that may cause confusion with rocuronium bromide. Affected products have specific NDC and batch numbers.
Labeling: Incorrect Barcode: Product barcode incorrectly identifies the product as rocuronium bromide injection 100 mg per 10 mL instead of sodium chloride injection 23.4%, 120 mEq per 30 mL.
“Ritedose 23.4% Sodium Chloride Injection Recall: Incorrect Barcode Labeling.” GovInfoNow, updated August 18, 2026. https://govinfonow.com/recall/35024-ritedose-23-4-sodium-chloride-injection-recall-incorrect-barcode-labeling. Based on FDA recall #D-0745-2022 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0745-2022%22&limit=1).
The Food and Drug Administration announced on April 1, 2022, that The Ritedose Corporation voluntarily recalled 3,795 prefilled syringes of 23.4% Sodium Chloride Injection due to an incorrect barcode. The agency said the error misidentifies the product as rocuronium bromide injection.
How to tell if you have it
Brand: Ritedose
Product: 23.4% Sodium Chloride Injection, 120 mEq per 30 mL (4 mEq/mL), 50 mL prefilled syring
NDC: 65302-509-30
Lots: 210137-01, 220026-01, 220050-01
Distribution: Nationwide in the USA
The hazard
The product barcode incorrectly identifies the product as rocuronium bromide injection 100 mg per 10 mL instead of sodium chloride injection 23.4%, 120 mEq per 30 mL, according to the FDA.
Context
GovInfoNow's records show The Ritedose Corporation has one other recall on record since July 21, 2023, involving Cromolyn Sodium Oral Solution due to a CGMP deviation risk. Other recent recalls of similar products include Fresenius Kabi 0.9% Sodium Chloride Injection Recall (March 11, 2026), American Regent Levocarnitine Injection Recall (April 16, 2026), and ICU Medical Recalls Potassium Chloride Injection Due to Label Error (Oct. 29, 2025).
How to tell if you have this one
Check for the product name '23.4% Sodium Chloride Injection, 120 mEq per 30 mL' on the label. Look for NDC number 65302-509-30 and batch numbers 210137-01, 220026-01, or 220050-01.
Brand
Ritedose
Category
Drug
Based on the official FDA remedy
What to do — step by step
Check Product Label
Verify the product name and NDC number to ensure it matches the correct saline injection.
Where it went and when
Where it was distributed
Distributed nationwide.
Nationwide
Not listed
FDA distribution: “Nationwide in the USA” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA terminated this recall 8 months after the firm started it.
1Firm started the recall
2FDA classified it Class III
3Published in FDA’s Enforcement Report
4FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
Official source: FDA Recall #D-0745-2022 (April 1, 2022) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0745-2022 to see it in context.
Plain-language summary written by qwen3:4b on August 18, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.